About Tempus
Tempus is a biotechnology company that employs AI-driven precision medicine. By extracting insights from a vast library of clinical and molecular data, Tempus aims to create personalized healthcare information to enhance diagnostics in fields such as cardiology, neuropsychiatry, radiology, and infectious diseases. The company’s mission is to help patients lead longer lives, supported by advanced machine learning tools and technology. Founded by Eric Lefkofsky in 2015, Tempus is headquartered in Chicago, IL.
Tempus Industries Press Mentions
Stay in the know about the latest news on Tempus Industries
Investors in Tempus Industries
Discover investors in Tempus Industries stock and explore their portfolio companies
Tempus Industries Management
Leadership team at Tempus Industries
Management Team
Kevin White, Ph.D.
Chief Science Officer
Vanessa Rollings
Chief Financial Officer
Eric Lefkofsky
Founder & Chief Executive Officer
Ryan Fukushima
Chief Operating Officer
Marc Yoskowitz
Chief Strategy Officer
Mike Yasiejko
Chief Commercial Officer
Gary Palmer, MD
Chief Medical Officer
Shane Colley
Chief Technology Officer
Chief Strategy Officer
Chief People Officer
Board Members
David Agus, MD
A. Keith Stewart, MB.CHB., MBA
Steve Case
Revolution
Arul M. Chinnaiyan, MD, Ph.D.
Peter Barris
New Enterprise Associates
Funmi Olopade, MD
Eric Topol, MD
John Doerr
Kleiner Perkins
Register To Buy and Sell Shares
For more details on private stock price information, financing and valuation for Tempus, register or login.
- Tempus's current valuation
- Tempus's stock price
- Explore available deals for Tempus and other companies
- Access deal offering documents
- Pre-Ipomarket's exclusive data and insights, including:
- Cap tables showing funding history by Share Class and Liquidity Preferences
- Key Company Highlights
- Detailed Business Model
- Identified Risk Factors
By registering, you agree to StockMe's Terms of Use. Already registered? Log in
Frequently Asked Questions
How to invest in Tempus shares?
Accredited investors can purchase pre-IPO stock in companies like Tempus through platforms like pre-ipomarket. These shares are typically offered by early employees who are seeking liquidity for personal life events, such as buying a home or funding education. Investors can access these opportunities through funds similar to those used by hedge funds for large investors. While private company investments come with risks, they offer the potential for portfolio diversification, access to growth, and high returns. Learn more about our guided investment process.
How to sell Tempus shares?
Shareholders have the option to sell their Tempus stock through pre-ipomarket’s private company marketplace. The platform connects sellers with a large network of accredited investors who are interested in purchasing shares of private companies. Learn more about the streamlined and guided process for shareholders here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on pre-ipomarket. The first is if the company undergoes an exit event, such as an IPO, merger, or acquisition. In such cases, your shares and/or cash will be distributed directly to you. The second option, if eligible, is through an Express Deal. This allows you to sell your allocation of private shares in a specific company to another investor via the pre-ipomarket platform.
Why choose Pre-Ipomarket?
pre-ipomarket has simplified the process of buying and selling shares in private companies. The platform connects investors with shareholders, offering liquidity to early shareholders and providing accredited investors with access to private market opportunities. With low investment minimums and over 42K private placements completed across 450+ companies, pre-ipomarket is a leader in making "Private Markets for the Public."
